Dev Comp Immunol. 2026 Jun:179:105625.doi: 10.1016/j.dci.2026.105625. Epub 2026 May 12. Bombyx mori IML-2 modulates intracellular reactive oxygen species levels and downregulates glycolytic flux to inhibit viral infection 家蚕IML-2调节细胞内活性氧水平并下调糖酵解流量以抑制病毒感染
Sensors (Basel). 2026 Jun 18;26(12):3883.doi: 10.3390/s26123883. A Multi-Source Sensor Dataset for Spain: Integrating Air Quality, Meteorological, Mobility and Calendar Records. (IF:4).
Sensors (Basel). 2026 Jun 18;26(12):3883.doi: 10.3390/s26123883. A Multi-Source Sensor Dataset for Spain: Integrating Air Quality, Meteorological, Mobility and Calendar Records. (IF:4).
Sensors (Basel). 2026 Jun 18;26(12):3883.doi: 10.3390/s26123883. A Multi-Source Sensor Dataset for Spain: Integrating Air Quality, Meteorological, Mobility and Calendar Records. (IF:4).
Sensors (Basel). 2026 Jun 18;26(12):3883.doi: 10.3390/s26123883. A Multi-Source Sensor Dataset for Spain: Integrating Air Quality, Meteorological, Mobility and Calendar Records. (IF:4).
NPJ Precis Oncol. 2026 Jun 15.doi: 10.1038/s41698-026-01520-z. Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts. (IF:9.9).
SLAS Discov. 2026 Jun 10;42:100315.doi: 10.1016/j.slasd.2026.100315. Development of a rapid and sensitive EnLIGHT OMEGA assay for extracellular AGR2 detection in biological fluids. (IF:3.3).
Front Cell Dev Biol. 2026 Jun 17:14:1677758.doi: 10.3389/fcell.2026.1677758. Rare variants of GPSM2 associated with aneuploidy-mediated recurrent spontaneous abortion: mechanistic insights from siRNA knockdown modeling of hypothesized loss-of-function GPSM2罕见变异与非整倍体介导的复发性自然流产相关：基于siRNA敲低模型对功能丧失假说的机制研究 (IF:5.26).
Curr Res Food Sci. 2026 Jun 5;12:101464.doi: 10.1016/j.crfs.2026.101464. Shelf-life extension of lettuce using cell-penetrating peptide-peptide nucleic acid conjugates targeting <i>Sphingomonas</i> <i>paucimobilis</i>. (IF:7.7).
Clin Transl Oncol. 2026 Jun 2.doi: 10.1007/s12094-026-04423-4. Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence. (IF:2.7).
